Initiation and termination of DNA replication during S phase in relation to cyclins D1, E and A, p21WAF1, Cdt1 and the p12 subunit of DNA polymerase d revealed in individual cells by cytometry

Oncotarget

Volumn 6, Issue 14, 2015, Pages 11735-11750

  Darzynkiewicz, Zbigniew ^a   Zhao, Hong ^a   Zhang, Sufang ^a   Lee, Marietta Y W T ^a   Lee, Ernest Y C ^a   Zhang, Zhongtao ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Cell cycle; Cell proliferation; DNA replication; EdU labeling; Laser scanning cytometry; Polymerase ; S phase

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E; CYCLINE; DNA; DNA DIRECTED DNA POLYMERASE DELTA; KI 67 ANTIGEN; NUCLEAR PROTEIN; PROTEIN P12; REPLICATION LICENSING FACTOR CDT1; UNCLASSIFIED DRUG; CDKN1A PROTEIN, HUMAN; CDT1 PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DNA DIRECTED DNA POLYMERASE GAMMA; DNA POLYMERASE DELTA P12 SUBUNIT, HUMAN;

CANCER GROWTH; CANCER PROGNOSIS; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CYTOPATHOLOGY; DNA REPAIR; DNA REPLICATION; LASER SCANNING CYTOMETRY; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; TRANSCRIPTION INITIATION; TRANSCRIPTION TERMINATION; ANIMAL; HUMAN; METABOLISM; PHYSIOLOGY; PROCEDURES;

ANIMALS; CELL CYCLE PROTEINS; CYCLIN A; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA POLYMERASE III; DNA REPLICATION; HUMANS; LASER SCANNING CYTOMETRY; S PHASE;

EID: 84931437298     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4149     Document Type: Review

References (136)

1. Dolbeare F, Gratzner H, Pallavicini MG, Gray JW. Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci USA. 1983;80:5573-5577.
2. Dolbeare F, Gray JW. Use of restriction endonucleases and exonuclease III to expose halogenated pyrimidines for immunochemical staining. Cytometry. 1988; 9:631-635.
3. Li X, Traganos F, Melamed MR, Darzynkiewicz Z. Single step procedure for DNA strand-breaks labeling. Detection of apoptosis and DNA replication. Cytometry 1995; 20:172-180.
4. Salic, A, Mitchison, TJ. A chemical method for fast and sensitive detection of DNA synthesis in vivo. Proc Natl Acad Sci USA. 2008; 105:2415-2420.
5. Sun, Y, Sun, Y, Lin, G, Zhang, R, Zhang, K, Xie, J, Wang, L, Li, J. Multicolor flow cytometry analysis of the proliferations of T-lymphocyte subsets in vitro by EdU incorporation. Cytometry A 2012; 81:901-909.
6. Buck, SB, Bradford, J, Gee, KR, Agnew, BJ, Clarke, ST, Salic, A. Detection of S-phase cell cycle progression using 5-ethynyl-2'-deoxyuridine incorporation with click chemistry, an alternative to using 5-bromo-2'-deoxyuridine antibodies. BioTechniques 2008; 44:927-929.
7. Darzynkiewicz, Z, Traganos, F, Zhao, H, Halicka, HD, Li, J. Cytometry of DNA replication and RNA synthesis: Historical perspective and recent advances based on "click chemistry". Cytometry A 2011; 79:328-337.
8. Diermeier-Daucher, S, Clarke, ST, Hill, D, Vollmann-Zwerenz, A, Bradford, JA, Brockhoff, G. Cell type specific applicability of 5-ethynyl-2'-deoxyuridine (EdU) for dynamic proliferation assessment in flow cytometry. Cytometry A 2009; 75:535-546.
9. Kohlmeier, F, Maya-Mendoza, A, Jackson, DA. EdU induces DNA damage response and cell death in mESC in culture. Chromosome Res 2013; 21:87-100.
10. Zhao, H, Halicka, HD, Li, J, Biela, E, Berniak, K, Dobrucki, J, Darzynkiewicz, Z. DNA damage signaling, impairment of cell cycle progression, and apoptosis triggered by 5-ethynyl-2'-deoxyuridine incorporated into DNA. Cytometry A. 2013; 83:979-88.
11. Berniak K, Rybak P, Bernas T, Zarebski M, Biela E, Zhao, H, Darzynkiewicz Z, Dobrucki JW. Relationship between DNA damage response, initiated by camptothecin or oxidative stress, and DNA replication, analyzed by quantitative 3D image analysis. Cytometry A 2013;83A:913-824 (PMCID: PMC3888650).
12. Bernas T, Berniak K, Rybak P, Zarebski M, Zhao H, Darzynkiewicz Z, Dobrucki JW. Analysis of spatial correlations between patterns of DNA Damage Response and DNA replication in nuclei of cells subjected to replication stress or oxidative damage. Cytometry A. 2013; 83A:825-932.
13. Zhao H, Dobrucki J, Rybak P, Traganos F, Darzynkiewicz Z. Relationship of DNA damage signaling induced by DNA topoisomerase inhibitors camptothecin/topotecan, mitoxantrone or etoposide and DNA replication. Cytometry A 2012; 81A:45-51.
14. Zhao, H., Traganos F, Darzynkiewicz Z. Kinetics of the UV-induced DNA damage response in relation to cell cycle phase. Correlation with DNA replication. Cytometry A. 2010; 77A: 285-293.
15. Li B, Zhao H, Rybak P, Dobrucki JW, Darzynkiewicz Z, Kimmel M. Different rates of DNA replication at early versus late S-phase sections, Multiscale modeling of stochastic events related to DNA content/EdU incorporation bivariate distributions. Cytometry A. 2014; 85A:785-797.
16. Furia L, Pelicci PG, Faretta M. A computational platform for robotized fluorescence microscopy (I): highcontent image-based cell-cycle analysis. Cytometry A. 2013;83A:333-343.
17. Furia L, Pelicci PG, Faretta M. A computational platform for robotized fluorescence microscopy (II): DNA damage, replication, checkpoint activation, and cell cycle progression by high-content high-resolution multiparameter image-cytometry. Cytometry A. 2013; 83A:344-355.
18. Furia L, Pelicci P, Faretta M. High-resolution cytometry for high-content cell cycle analysis. Curr Protoc Cytom. 2014;70:7.41.1-7.
19. Furia L, Pelicci P, Faretta M. Confocal microscopy for high-resolution and high-content analysis of the cell cycle. Curr Protoc Cytom. 2014; 70:7.42.1-7.
20. WAF1, Cdt1, cyclin A, PCNA and Ki-67 in relation to DNA replication in individual cells. Cell Cycle. 2014;13: 3529-3540.
21. Pozarowski P, Holden E, Darzynkiewicz Z. Laser scanning cytometry: Principles and applications. An update. Meth Molec Biol. 2013; 913:187-212.
22. Lim S, Kaldis P. Cdks, cyclins and CKIs: roles beyond cell cycle regulation. Development. 2013; 140:3079-93.
23. Chang F, Steelman LS, Lee JT, Shelton JG, Navolanic PM, Blalock WL, Franklin RA, McCubrey JA. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia. 2003; 17:1263-1293.
24. Bretones G, Delgado MD, León J. Myc and cell cycle control. Biochim Biophys Acta. 2014 Apr 1. [Epub ahead of print].
25. Duronio RJ, Xiong Y. Signaling pathways that control cell proliferation. Cold Spring Harb Perspect Biol. 2013;5:a008904.
26. Manchado E, Eguren M, Malumbres M. The anaphasepromoting complex/cyclosome (APC/C): cell-cycledependent and-independent functions. Biochem Soc Trans. 2010; 38:65-71.
27. Chang L, Zhang Z, Yang J, McLaughlin SH, Barford, D. Molecular architecture and mechanism of the anaphasepromoting complex. Nature 2014; 513:388-393.
28. Giacinti C, Giordano A. RB and cell cycle progression. Oncogene. 2006; 25:5220-5227.
29. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell. 1992; 70:993-1006.
30. Gong JP, Li X, Traganos F, Darzynkiewicz Z. Expression of G1 and G2 cyclins measured in individual cells by multiparameter flow cytometry; a new tool in the analysis of the cell cycle. Cell Prolif 1994; 27: 357-371.
31. Darzynkiewicz Z, Gong JP, Juan G, Ardelt B, Traganos F. Cytometry of cyclin proteins. Cytometry 1996; 25:1-13.
32. Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 2009; 9:400-414.
33. Soria G, Gottifredi V. PCNA-coupled p21 degradation after DNA damage: The exception that confirms the rule?. DNA Repair (Amst) 2010; 9:358-364.
34. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993;75:817-825.
35. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 1993; 366:701-704.
36. Gartel AL, Radhakrishnan SK. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res. 2005; 65:3980-3985.
37. Child ES, Mann DJ. The intricacies of p21 phosphorylation. Cell Cycle. 2006; 5: 1313-1319.
38. Rössig L, Jadidi AS, Urbich C, Badorff C, Zeiher AM, Dimmeler S. Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells. Mol Cell Biol. 2001; 21:5644-5657.
39. Rodriguez R, Meuth M. Chk1 and p21 cooperate to prevent apoptosis during DNA replication fork stress. Mol. Biol. Cel.l 2006; 17:402-412.
40. Abbas, T, Dutta, A. CRL4Cdt2: master coordinator of cell cycle progression and genome stability. Cell Cycle. 2011; 10:241-249.
41. Havens, CG, Walter, JC. Mechanism of CRL4(Cdt2), a PCNA-dependent E3 ubiquitin ligase. Genes Dev. 2011; 25:1568-1582.
42. Rialland M, Sola F, Santocanale C. Essential role of human CDT1 in DNA replication and chromatin licensing. J Cell Sci. 2002; 115:1435-1440.
43. Nishitani H, Taraviras S, Lygerou Z, Nishimoto T. The human licensing factor for DNA replication Cdt1 accumulates in G1 and is destabilized after initiation of S-phase. J Biol Chem. 2001; 276:44905-44911.
44. Nishitani H, Sugimoto N, Roukos V, Nakanishi Y, Saijo M, Obuse C, Tsurimoto T, Nakayama KI, Nakayama K, Fujita M, Lygerou Z, Nishimoto T. Two E3 ubiquitin ligases, SCF-Skp2 and DDB1-Cul4, target human Cdt1 for proteolysis. EMBO J. 2006; 25:1126-1136.
45. Lee MY, Zhang S, Lin SH, Wang X, Darzynkiewicz Z, Zhang Z, Lee EY. The tail that wags the dog: p12, the smallest subunit of DNA polymerase delta, is degraded by ubiquitin ligases in response to DNA damage and during cell cycle progression. Cell Cycle. 2013; 13:23-31.
46. Zhang S, Zhou Y, Sarkeshik A, Yates JR, Thomson T, Zhang Z, Lee EY, Lee MY. Identification of RNF8 as a ubiquitin ligase involved in targeting the p12 subunit of DNA polymerase δ for degradation in response to DNA damage. J Biol Chem. 2013; 288:2941-2950.
47. Huang, QM, Akashi, T, Masuda, Y, Kamiya, K, Takahashi, T, Suzuki, M. Roles of POLD4, smallest subunit of DNA polymerase delta, in nuclear structures and genomic stability of human cells. Biochem Biophys Res Commun. 2010; 391:542-546.
48. Tsanov, N, Kermi, C, Coulombe, P, Van der Laan, S, Hodroj, D, Maiorano, D. PIP degron proteins, substrates of CRL4Cdt2, and not PIP boxes, interfere with DNA polymerase eta and kappa focus formation on UV damage. Nucleic Acids Res. 2014; 42:3692-36706.
49. Burgers, PM. Polymerase dynamics at the eukaryotic DNA replication fork. J Biol Chem. 2009; 284:4041-4045.
50. Garg P, Burgers PM. DNA polymerases that propagate the eukaryotic DNA replication fork. Crit Rev Biochem Mol Biol. 2005; 40:115-128.
51. Kunkel TA, Burgers PM. Dividing the workload at a eukaryotic replication fork. Trends Cell Biol. 2008; 18:521-527.
52. Zhang S, Zhou Y, Trusa S, Meng X, Lee EY, Lee MY. A novel DNA damage response: rapid degradation of the p12 subunit of DNA polymerase delta. J Biol Chem. 2007; 282:15330-15340.
53. Chea J, Zhang S, Zhao H, Zhang Z, Lee EY, Darzynkiewicz Z, Lee MY. Spatiotemporal recruitment of human DNA polymerase delta to sites of UV damage. Cell Cycle. 2012; 11:2885-2895.
54. Lee MY, Zhang S, Lin SH, Chea J, Wang X, LeRoy C, Wong A, Zhang Z, Lee EY. Regulation of human DNA polymerase delta in the cellular responses to DNA damage. Environ Mol Mutagen. 2012; 53:683-698.
55. Zhang S, Zhao H, Darzynkiewicz Z, Zhou P, Zhang Z, Lee EY, Lee MY. A novel function of CRL4Cdt2: regulation of the subunit structure of DNA polymerase delta in response to DNA damage and during the S phase. J Biol Chem. 2013; 288:29950-29961.
56. Lin, SH, Wang, X, Zhang, S, Zhang, Z, Lee, EY, Lee, MY. Dynamics of enzymatic interactions during short flap human Okazaki fragment processing by two forms of human DNA polymerase δ. DNA Repair (Amst). 2013; 12:922-935.
57. Meng, X, Zhou, Y, Lee, EY, Lee, MY, Frick, DN. The p12 subunit of human polymerase delta modulates the rate and fidelity of DNA synthesis. Biochemistry. 2010; 49:3545-3554.
58. Meng, X, Zhou, Y, Zhang, S, Lee, EY, Frick, DN, Lee, MY. DNA damage alters DNA polymerase delta to a form that exhibits increased discrimination against modified template bases and mismatched primers. Nucleic Acids Res 2009; 37:647-657.
59. Huang, QM, Tomida, S, Masuda, Y, Arima, C, Cao, K, Kasahara, TA, Osada, H, Yatabe, Y, Akashi, T, Kamiya, K, Takahashi, T, Suzuki, M. Regulation of DNA polymerase POLD4 influences genomic instability in lung cancer. Cancer Res. 2010; 70:8407-8416.
60. Cohen LS, Studzinski GP. Correlation between cell enlargement and nucleic acid and protein content of HeLa cells in unbalanced growth produced by inhibitors of DNA synthesis. J Cell Physiol. 1967; 69:331-339.
61. Gong JP, Traganos F, Darzynkiewicz Z. Growth imbalance and altered expression of cyclins B1, A. E and D3 in MOLT-4 cells synchronized in the cell cycle by inhibitors of DNA replication. Cell Growth & Different. 1995; 6:1485-1493.
62. Kurose A, Tanaka T, Huang X, Traganos F, Darzynkiewicz Z. Synchronization in the cell cycle by inhibitors of DNA replication induces histone H2AX phosphorylation, an indication of DNA damage. Cell Prolif. 2006; 39:231-240.
63. Cooley A, Zelivianski S, Jeruss JS. Impact of cyclin E overexpression on Smad3 activity in breast cancer cell lines. Cell Cycle. 2010, 9:4900-4907.
64. Morris L, Allen KE, La Thangue NB. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators. Nat Cell Biol. 2000; 2:232-239.
65. Ma T, Van Tine BA, Wei Y, Garrett MD, Nelson D, Adams PD, Wang J, Qin J, Chow LT, Harper JW. Cell cycleregulated phosphorylation of p220(NPAT) by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription. Genes Dev. 2000; 14:2298-2313.
66. Tarapore P, Okuda M, Fukasawa K. A mammalian in vitro centriole duplication system: evidence for involvement of CDK2/cyclin E and nucleophosmin/B23 in centrosome duplication. Cell Cycle. 2002; 1:75-81.
67. Tsang WY, Spektor A, Luciano DJ, Indjeian VB, Chen Z, Salisbury JL, Sánchez I, Dynlacht BD. CP110 cooperates with two calcium-binding proteins to regulate cytokinesis and genome stability. Mol Biol Cell. 2006; 17:3423-3344.
68. Yam, CH, Fung, TK, Poon, RY. Cyclin A in cell cycle control and cancer. Cell Mol Life Sci. 2002; 59:1317-1326.
69. Pagano, M, Pepperkok, R, Verde, F, Ansorge, W, Draetta, G. Cyclin A is required at two points in the human cell cycle. EMBO J. 1992; 11:961-971.
70. Bendris, N, Lemmers, B, Blanchard, JM, Arsic, N. Cyclin A2 mutagenesis analysis: A new insight into CDK activation and cellular localization requirements. PLoS ONE 2011; 6:e22879.
71. Woo, RA, Poon, RY. Cyclin-dependent kinases and S phase control in mammalian cells. Cell Cycle. 2003; 2:316-324.
72. Kabeche L, Compton DA. Cyclin A regulates kinetochore microtubules to promote faithful chromosome segregation. Nature. 2013; 502:110-113.
73. Gong, D. & Ferrell, J. E. The roles of cyclin A2, B1, and B2 in early and late mitotic events. Mol Biol Cell. 2010; 21:3149-3161.
74. Juan, G, Li, X, Darzynkiewicz, Z. Correlation between DNA replication and expression of cyclins A and B1 in individual MOLT-4 cells. Cancer Res. 1997; 57:803-807.
75. Darzynkiewicz, Z, Juan, G, Traganos, F. Cytometry of cell cycle regulatory proteins. Prog Cell Cycle Res. 2003; 5:533-542.
76. Juan, G, Traganos, F, James, WM, Ray, JM, Roberge, M, Sauve, DM, Anderson, H, Darzynkiewicz, Z. Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis. Cytometry 1998; 32:71-77.
77. Weis MC, Avva J, Jacobberger JW, Sreenath SN. A datadriven, mathematical model of mammalian cell cycle regulation. PLoS One. 2014;13:e97130.
78. Avva J, Weis MC, Sramkoski RM, Sreenath SN, Jacobberger JW. Dynamic expression profiles from static cytometry data: component fitting and conversion to relative, "same scale" values. PLoS One. 2012;7:e38275.
79. Jacobberger JW, Avva J, Sreenath SN, Weis MC, Stefan T. Dynamic epitope expression from static cytometry data: principles and reproducibility. PLoS One. 2012; 7:e30870.
80. Celis, JE, Madsen, P, Nielsen, S, Celis, A. Nuclear patterns of cyclin (PCNA) antigen distribution subdivide S-phase in cultured cells-some applications of PCNA antibodies. Leuk Res. 1986; 10:237-349.
81. Leonardi E, Girlando S, Serio G, Mauri FA, Perrone G, Scampini S, Dalla Palma P, Barbareschi M. PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables". J Clin Pathol. 1992; 45:416-419.
82. Matsushita, K, Cha, EK, Matsumoto, K, Baba, S, Chromecki, TF, Fajkovic, H, Sun, M, Karakiewicz, PI, Scherr, DS, Shariat, SF. Immunohistochemical biomarkers for bladder cancer prognosis. Int J Urol. 2011; 18:616-629.
83. Kelman, Z. PCNA: structure, functions and interactions. Oncogene. 1997; 14:629-640.
84. Kuriyan, J, O'Donnell, M. Sliding clamps of DNA polymerases. J Mol Biol. 1993; 234: 915-925.
85. Bowman, GD, Goedken, ER, Kazmirski, SL, O'Donnell, M, Kuriyan, J. DNA polymerase clamp loaders and DNA recognition. FEBS Lett. 2005; 579:863-867.
86. Mailand N, Gibbs-Seymour I, Bekker-Jensen S. Regulation of PCNA-protein interactions for genome stability. Nature reviews. Molecular cell biology. 2013;14: 269-282.
87. Moldovan, GL, Pfander, B, Jentsch, S. PCNA, the maestro of the replication fork. Cell. 2007; 129:665-679.
88. Warbrick E. PCNA binding through a conserved motif. BioEssays: news and reviews in molecular, cellular and developmental biology. 1998; 20:195-199.
89. Gilljam KM, Feyzi E, Aas PA, Sousa MM, Müller R, Vågbø CB, Catterall TC, Liabakk NB, Slupphaug G, Drabløs F, Krokan HE, Otterlei M. Identification of a novel, widespread, and functionally important PCNA-binding motif. The Journal of Cell Biology. 2009; 186: 645-654.
90. Mailand N, Gibbs-Seymour I, Bekker-Jensen S. Regulation of PCNA-protein interactions for genome stability. Nature reviews. Molecular cell biology. 2013; 14:269-282.
91. Gerdes, J, Schwab, U, Lemke, H, Stein, H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer. 1983; 31:13-20.
92. Bruno, S, Darzynkiewicz, Z. Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells. Cell Prolif. 1992; 25:31-40.
93. Endl, E, Gerdes, J. The Ki-67 protein: fascinating forms and an unknown function. Exp Cell Res. 2000; 257:231-237.
94. Rahmanzadeh, R, Huttmann, G, Gerdes, J, Scholzen, T. Chromophore-assisted light inactivation of pKi-67 leads to inhibition of ribosomal RNA synthesis. Cell Prolif. 2007; 40:422-430.
95. Bullwinkel, J, Baron-Luhr, B, Ludemann, A, Wohlenberg, C, Gerdes, J, Scholzen, T. Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. J Cell Physiol. 2006; 206:624-635.
96. Darzynkiewicz, Z, Traganos, F, Sharpless, T, Melamed, MR. Lymphocyte stimulation: a rapid multiparameter analysis. Proc Natl Acad Sci USA. 1976; 73:2881-2824.
97. Darzynkiewicz, Z, Sharpless, T, Staiano-Coico, L, Melamed, MR. Subcompartments of the G1 phase of cell cycle detected by flow cytometry. Proc Natl Acad Sci USA. 1980; 77:6696-9.
98. Darzynkiewicz, Z, Traganos, F, Melamed, MR. New cell cycle compartments identified by multiparameter flow cytometry. Cytometry. 1980; 1:98-108.
99. Darzynkiewicz, Z, Crissman, H, Traganos, F, Steinkamp, J. Cell heterogeneity during the cell cycle. J Cell Physiol. 1982; 113:465-474.
100. Andreeff, M, Darzynkiewicz, Z, Sharpless, TK, Clarkson, BD, Melamed, MR. Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA. Blood. 1980; 55:282-293.
101. Darzynkiewicz, Z, Evenson, DP, Staiano-Coico, L, Sharpless, TK, Melamed, ML. Correlation between cell cycle duration and RNA content. J Cell Physiol. 1979; 100:425-438.
102. Darzynkiewicz, Z. Cellular RNA content, a feature correlated with cell kinetics and tumor prognosis. Leukemia. 1988; 2:777-787.
103. Frisa PS, Jacobberger JW. Cytometry of chromatin bound Mcm6 and PCNA identifies two states in G1 that are separated functionally by the G1 restriction point. BMC Cell Biol. 2010; Apr 16;11:26. doi: 10.1186/1471-2121-11-2611: PMID:20398392.
104. Bruno S, Bauer K, Crissman HA, Darzynkiewicz Z. Changes in cell nuclei during S phase: Progressive chromatin condensation and altered expression of the proliferation-associated nuclear proteins Ki-67, p-105, cyclin/PCNA and p34. Exp Cell Res. 1991; 196:99-106.
105. Gong JP, Traganos F, Darzynkiewicz Z. Discrimination of G2 and mitotic cells by flow cytometry based on different expression of cyclins B1 and A. Exp Cell Res. 1995; 220:226-231.
106. Prescott DM, Bender MA, Synthesis of RNA and protein during mitosis in mammalian tissue culture cells. Exp Cell Res. 1963; 26:260-68.
107. Tarnowka MA, Baglioni C. Regulation of protein synthesis in mitotic HeLa cells. J Cell Physiol. 1979; 99:353-367.
108. Johansson P, Jeffery J, Al-Ejeh F, Schulz RB, Callen DF, Kumar R, Khanna KK. SCF-FBXO31 E3 ligase targets DNA replication factor Cdt1 for proteolysis in the G2 phase of cell cycle to prevent re-replication. J Biol Chem. 2014; 289:18514-18525.
109. Chandrasekaran S, Tan TX, Hall JR, Cook JG. Stressstimulated mitogen-activated protein kinases control the stability and activity of the Cdt1 DNA replication licensing factor. Mol Cell Biol. 2011; 31:4405-4416.
110. Ballabeni A, Park IH, Zhao R, Wang W, Lerou PH, Daley GQ, Kirschner MW. Cell cycle adaptations of embryonic stem cells. Proc Natl Acad Sci USA. 2011; 108:19252-19257.
111. Wohlschlegel JA, Dwyer BT, Dhar SK, Cvetic C, Walter JC, Dutta A. Inhibition of eukaryotic DNA replication by geminin binding to Cdt1. Science. 2000; 290:2309-2312.
112. Yanow SK, Lygerou Z, Nurse P. Expression of Cdc18/Cdc6 and Cdt1 during G2 phase induces initiation of DNA replication. EMBO J. 2001; 20:4648-4656.
113. Matsushita K, Cha EK, Matsumoto K, Baba S, Chromecki TF, Fajkovic H, Sun M, Karakiewicz PI, Scherr DS, Shariat SF. Immunohistochemical biomarkers for bladder cancer prognosis. Int J Urol. 2011; 18:616-629.
114. Marchiò C, Balmativola D, Castiglione R, Annaratone L, Sapino A. Predictive diagnostic pathology in the target therapy era in breast cancer. Curr Drug Targets. 2015 Feb. [Epub ahead of print].
115. Stuart-Harris R, Caldas C, Pinder SE, Pharoah P. Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients. Breast. 2008; 17:323-334.
116. Santala S, Talvensaari-Mattila A, Soini Y, Honkavuori-Toivola M, Santala M. High expression of cyclin A is associated with poor prognosis in endometrial endometrioid adenocarcinoma. Tumour Biol. 2014; 35:5395-5399.
117. Gopinathan L, Tan SL, Padmakumar VC, Coppola V, Tessarollo L, Kaldis P. Loss of Cdk2 and cyclin A2 impairs cell proliferation and tumorigenesis. Cancer Res. 2014;74:3870-3879.
118. Jernman J, Välimäki MJ, Hagström J, Louhimo J, Haapasalo H, Arola J, Haglund C. Cyclin A predicts metastatic potential of rectal neuroendocrine tumors. Hum Pathol. 2014; 45:1605-1609.
119. Klintman M, Strand C, Ahlin C, Beglerbegovic S, Fjällskog ML, Grabau D, Gudlaugsson E, Janssen EA, Lövgren K, Skaland I, Bendahl PO, Malmström P, Baak JP, Fernö M. The prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative premenopausal breast cancer. PLoS One. 2013 Dec 4; 8:e81902.
120. Huang L, Ren F, Tang R, Feng Z, Chen G. Prognostic value of expression of cyclin E in gastrointestinal cancer: A systematic review and meta-analysis. Technol Cancer Res Treat. 2015 Jan 26. pii: 1533034614568098. [Epub ahead of print].
121. Alsina M, Landolfi S, Aura C, Caci K, Jimenez J, Prudkin L, Castro S, Moreno D, Navalpotro B, Tabernero J, Scaltriti M. Cyclin E amplification/overexpression is associated with poor prognosis in gastric cancer. Ann Oncol. 2015 ;26:438-439.
122. Gao S, Ma JJ, Lu C. Prognostic value of cyclin E expression in breast cancer: a meta-analysis. Tumour Biol. 2013; 34:3423-3430.
123. Gong JP, Ardelt B, Traganos F, Darzynkiewicz Z. Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines. Cancer Res. 1994; 54:4285-4288.
124. Sangfelt O, Cepeda D, Malyukova A, van Drogen F, Reed SI. Both SCF(Cdc4alpha) and SCF(Cdc4gamma) are required for cyclin E turnover in cell lines that do not overexpress cyclin E. Cell Cycle. 2008; 7:1075-1082.
125. Stead E, White J, Faast R, Conn S, Goldstone S, Rathjen J, Dhingra U, Rathjen P, Walker D, Dalton S. Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities. Oncogene. 2002; 21:8320-8333.
126. Wheeler LW, Lents NH, Baldassare JJ. Cyclin A-CDK activity during G1 phase impairs MCM chromatin loading and inhibits DNA synthesis in mammalian cells. Cell Cycle. 2008; 7:2179-2188.
127. Katsuno Y, Suzuki A, Sugimura K, Okumura K, Zineldeen DH, Shimada M, Niida H, Mizuno T, Hanaoka F, Nakanishi M. Cyclin A-Cdk1 regulates the origin firing program in mammalian cells. Proc Natl Acad Sci USA. 2009; 106:3184-3189.
128. Frum R, Ramamoorthy M, Mohanraj L, Deb S, Deb SP. MDM2 controls the timely expression of cyclin A to regulate the cell cycle. Mol Cancer Res. 2009; 7:1253-1267.
129. Kirkpatrick P. Technology: Specificity concerns with antibodies for receptor mapping. Nature Reviews Drug Discovery 8, 278 (April 2009) doi:10.1038/nrd2854.
130. Faaber P, Rijke TP, van de Putte LB, Capel PJ, Berden JH.Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes. J Clin Invest. 1986; 77:1824-30.
131. Monici M. Cell and tissue autofluorescence research and diagnostic applications. Biotechnology Annu Rev. 2005; 11:227-256.
132. Voorhout WF, Leunissen-Bijvelt JJ, Leunissen JLM, M. Verkleij AJ. Steric hindrance in immunolabelling. J Microscopy. 1986; 141:303-310.
133. Bruno S, Gorczyca W, Darzynkiewicz Z. The effect of ionic strength in immunocytochemical detection of the proliferation associated nuclear antigens p120, PCNA and the protein reacting with Ki-67 antibody. Cytometry. 1992; 13:496-501.
134. Kurki P, Vanderlaan M, Dolbeare F, Gray J, Tan EM. Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. Exp Cell Res. 1986; 166:209-219.
135. Sasaki K, Kurose A, Ishida Y. Flow cytometric analysis of the expression of PCNA during the cell cycle in HeLa cells and effects of the inhibition of DNA synthesis on it. Cytometry 1993; 14:876-882.
136. Landberg G, Ross G. Flow cytometric analysis of proliferation associated nuclear antigen using washless staining of unfixed cells. Cytometry 1992; 13:230-240.